AQR Capital Management Portfolio holdings
AUM
$121B
1-Year Return
23.38%
This Quarter Return
+10.91%
1 Year Return
+23.38%
3 Year Return
+85.44%
5 Year Return
+156.19%
10 Year Return
+370.97%
AUM
$43.9B
AUM Growth
+$2.87B
(+7%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-2.45%
Top 10 Holdings %
Top 10 Hldgs %
13.25%
Holding
2,343
New
170
Increased
997
Reduced
1,015
Closed
151
Top Buys
| 1 |
Verizon
VZ
|
+$108M |
| 2 |
Humana
HUM
|
+$108M |
| 3 |
AT&T
T
|
+$105M |
| 4 |
Kroger
KR
|
+$94.3M |
| 5 |
3M
MMM
|
+$90.8M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
+$149M |
| 2 |
JPMorgan Chase
JPM
|
+$108M |
| 3 |
Merck
MRK
|
+$90.2M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$86.7M |
| 5 |
Apple
AAPL
|
+$76.8M |
Sector Composition
| 1 | Technology | 19.59% |
| 2 | Healthcare | 16.25% |
| 3 | Financials | 11.85% |
| 4 | Industrials | 11.35% |
| 5 | Consumer Discretionary | 10.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Bioventus
BVS
$482M
| $273K | ﹤0.01% |
+104,471
| New | +$273K |
|
2002
B. Riley Financial
RILY
$156M
| $272K | ﹤0.01% |
7,961
-459
| -5% | -$15.7K |
|
2003
Cogent Biosciences
COGT
$1.77B
| $272K | ﹤0.01% |
+23,549
| New | +$272K |
|
2004
Costamare
CMRE
$1.47B
| $271K | ﹤0.01% |
29,221
+18,201
| +165% | +$169K |
|
2005
Shutterstock
SSTK
$724M
| $271K | ﹤0.01% |
5,140
-10,224
| -67% | -$539K |
|
2006
Zillow
Z
$21.8B
| $269K | ﹤0.01% |
8,501
-4,756
| -36% | -$151K |
|
|
BLUE
2007
DELISTED
bluebird bio
BLUE
| $266K | ﹤0.01% |
1,965
-837
| -30% | -$113K |
|
2008
Repare Therapeutics
RPTX
$73.5M
| $262K | ﹤0.01% |
+17,807
| New | +$262K |
|
2009
Arvinas
ARVN
$583M
| $261K | ﹤0.01% |
7,623
-8,425
| -52% | -$288K |
|
2010
Spirit AeroSystems
SPR
$4.82B
| $261K | ﹤0.01% |
9,118
-60,088
| -87% | -$1.72M |
|
2011
Pathward Financial
CASH
$1.74B
| $260K | ﹤0.01% |
6,033
-4,774
| -44% | -$206K |
|
2012
Amplify Energy
AMPY
$151M
| $259K | ﹤0.01% |
29,475
| – | – |
|
2013
Tennant Co
TNC
$1.52B
| $258K | ﹤0.01% |
+4,188
| New | +$258K |
|
2014
CryoPort
CYRX
$503M
| $257K | ﹤0.01% |
+14,806
| New | +$257K |
|
|
HLGN
2015
DELISTED
Heliogen, Inc.
HLGN
| $257K | ﹤0.01% |
10,505
+10,136
| +2,747% | +$248K |
|
2016
Northwest Bancshares
NWBI
$1.86B
| $256K | ﹤0.01% |
+18,295
| New | +$256K |
|
2017
Brinker International
EAT
$7.04B
| $256K | ﹤0.01% |
8,013
-31,320
| -80% | -$999K |
|
2018
Helix Energy Solutions
HLX
$914M
| $255K | ﹤0.01% |
34,620
-80,757
| -70% | -$596K |
|
|
MAGN
2019
Magnera Corporation
MAGN
$420M
| $255K | ﹤0.01% |
7,068
-1,830
| -21% | -$66.1K |
|
2020
Foghorn Therapeutics
FHTX
$326M
| $254K | ﹤0.01% |
39,817
-30,770
| -44% | -$196K |
|
|
HIBB
2021
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $254K | ﹤0.01% |
3,721
-2,989
| -45% | -$204K |
|
|
TWOU
2022
DELISTED
2U, Inc.
TWOU
| $253K | ﹤0.01% |
1,383
-2,616
| -65% | -$479K |
|
2023
Triumph Financial, Inc.
TFIN
$1.52B
| $253K | ﹤0.01% |
5,175
+188
| +4% | +$9.19K |
|
2024
Alphatec Holdings
ATEC
$2.42B
| $251K | ﹤0.01% |
20,332
+82
| +0.4% | +$1.01K |
|
2025
Gorman-Rupp
GRC
$1.13B
| $251K | ﹤0.01% |
9,783
-21,529
| -69% | -$552K |
|